A Test for Multiple Binary Endpoints with Continuous Latent Distribution in Clinical Trials

被引:0
|
作者
Takuma Ishihara
Kouji Yamamoto
机构
[1] Gifu University Hospital,Innovative and Clinical Research Promotion Center
[2] Yokohama City University School of Medicine,Department of Biostatistics
关键词
Latent variable; Non-inferiority; Superiority;
D O I
暂无
中图分类号
学科分类号
摘要
In clinical trials, two or more binary responses obtained by dichotomizing continuous responses are often employed as multiple primary endpoints. Testing procedures for multiple binary variables with latent distribution have not yet been adequately discussed. Based on the association measure among latent variables, we provide a statistic for testing the superiority of at least one binary endpoint. In addition, we propose a testing procedure with a framework in which the trial efficacy is confirmed only when there is superiority of at least one endpoint and non-inferiority of the remaining endpoints. The performance of the proposed procedure is evaluated through simulations.
引用
收藏
页码:463 / 480
页数:17
相关论文
共 50 条
  • [41] Analysis of Group Randomized Trials with Multiple Binary Endpoints and Small Number of Groups
    Lee, Ji-Hyun
    Schell, Michael J.
    Roetzheim, Richard
    PLOS ONE, 2009, 4 (10):
  • [42] Multiplicity adjustment for multiple endpoints in clinical trials with multiple doses of an active treatment
    Quan, H
    Luo, XH
    Capizzi, T
    STATISTICS IN MEDICINE, 2005, 24 (14) : 2151 - 2170
  • [43] Clinical trials: Surrogate endpoints or hard endpoints?
    Kuller, LH
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (2A): : 59E - 61E
  • [44] A mixed approach for proving non-inferiority in clinical trials with binary endpoints
    Rousson, Valentin
    Seifert, Burkhardt
    BIOMETRICAL JOURNAL, 2008, 50 (02) : 190 - 204
  • [45] Interim monitoring of clinical trials based on long-term binary endpoints
    Marschner, IC
    Becker, SL
    STATISTICS IN MEDICINE, 2001, 20 (02) : 177 - 192
  • [46] A Primer of Quasi-Exact Tests for Randomized Clinical Trials with Binary Endpoints
    Lloyd, Chris J.
    Ripamonti, Enrico
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2024,
  • [47] A Novel Longitudinal Rank-Sum Test for Multiple Primary Endpoints in Clinical Trials: Applications to Neurodegenerative Disorders
    Xu, Xiaoming
    Ghosh, Dhrubajyoti
    Luo, Sheng
    CPP Integrated Parkinsons Database
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2025,
  • [48] Review of calculation of conditional power, predictive power and probability of success in clinical trials with continuous, binary and time-to-event endpoints
    Madan G. Kundu
    Sandipan Samanta
    Shoubhik Mondal
    Health Services and Outcomes Research Methodology, 2024, 24 : 14 - 45
  • [49] Review of calculation of conditional power, predictive power and probability of success in clinical trials with continuous, binary and time-to-event endpoints
    Kundu, Madan G.
    Samanta, Sandipan
    Mondal, Shoubhik
    HEALTH SERVICES AND OUTCOMES RESEARCH METHODOLOGY, 2024, 24 (01) : 14 - 45
  • [50] Endpoints in oncology clinical trials
    Kilickap, Saadettin
    Demirci, Umut
    Karadurmus, Nuri
    Dogan, Mutlu
    Akinci, Bulent
    Sendur, Mehmet Ali Nahit
    JOURNAL OF BUON, 2018, 23 : S1 - S6